Summary: According to the Vivos Therapeutics fourth-quarter and total-year 2023 report, there has been beneficial momentum considering the fact that the Food and drug administration clearance of its Treatment oral appliances for severe OSA in grownups. This momentum is evidenced … [Read more...]